3 assets in Solitary Fibrous Tumor

Therapeutic assets addressing Solitary Fibrous Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fludeoxyglucose Solitary Fibrous Tumor	Jonsson Comprehensive Cancer Center	P1	CC (43)
okn4395 Solitary Fibrous Tumor	Epkin	P1	CC (43)
Pembrolizumab Solitary Fibrous Tumor	Epkin	P1	CC (43)